Karen Mossman

Karen Mossman

Department of Pathology and Molecular Medicine, McMaster University

Affiliated withMcMaster University

Research Area

Biography

Karen Mossman has not added Biography.
If you are Karen Mossman and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1
Year
Handling of the Cotton Rat in Studies for the Pre-clinical Evaluation of Oncolytic Viruses
Publication title

Cited by 3

2014

Other Publications

Article
Year
Herpes simplex virus ICP0 and ICP34.5 counteract distinct interferon-induced barriers to virus replication.

Journal of virology| PubMed ID: 11799195

2002
2002
2004
2004
2005
Herpesviruses and the innate immune response.

Viral immunology| PubMed ID: 16035939

2005
The role of ICP0-Null HSV-1 and interferon signaling defects in the effective treatment of breast adenocarcinoma.

Molecular therapy : the journal of the American Society of Gene Therapy| PubMed ID: 16140040

2005
2005
2006
2006
2006
2006
Distinct functional motifs within the IL-17 receptor regulate signal transduction and target gene expression.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 17456598

2007
2007
2008
Cigarette smoke suppresses type I interferon-mediated antiviral immunity in lung fibroblast and epithelial cells.

Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research| PubMed ID: 18338949

2008
2008
2009
Cutting edge: FimH adhesin of type 1 fimbriae is a novel TLR4 ligand.

Journal of immunology (Baltimore, Md. : 1950)| PubMed ID: 18981086

2008
2009
2008
2009
2009
2009
Mechanisms employed by herpes simplex virus 1 to inhibit the interferon response.

Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research| PubMed ID: 19694546

2009
2009
2010
2010
Recognition of virus infection and innate host responses to viral gene therapy vectors.

Molecular therapy : the journal of the American Society of Gene Therapy| PubMed ID: 20551916

2010
2010
2010
Adaptive antiviral immunity is a determinant of the therapeutic success of oncolytic virotherapy.

Molecular therapy : the journal of the American Society of Gene Therapy| PubMed ID: 21119618

2011
2011
2011
Retroviral expression of MIR2 decreases both surface MHC class I and the alloimmune CTL response.

Journal of tissue engineering and regenerative medicine| PubMed ID: 21695793

2011
2011
2011
2009
Methods related to molecular virology.

Methods (San Diego, Calif.)| PubMed ID: 22050902

2011
2012
2012
2012
2012
2013
2013
2013
2013
2013
2013
Oncolytic virotherapy and immunogenic cancer cell death: sharpening the sword for improved cancer treatment strategies.

Molecular therapy : the journal of the American Society of Gene Therapy| PubMed ID: 24048442

2014
Immunogenic HSV-mediated oncolysis shapes the antitumor immune response and contributes to therapeutic efficacy.

Molecular therapy : the journal of the American Society of Gene Therapy| PubMed ID: 24343053

2014
2013
2014
2013
2014
Extracellular dsRNA: its function and mechanism of cellular uptake.

Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research| PubMed ID: 24905198

2014
Type-I interferon signaling through ISGF3 complex is required for sustained Rip3 activation and necroptosis in macrophages.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 25049377

2014
Danger, diversity and priming in innate antiviral immunity.

Cytokine & growth factor reviews| PubMed ID: 25081316

2014